Basics Caribou Biosciences, Inc. IPO Date: July 23, 2021 Sector: Healthcare Industry: Biotech Market Cap: $90.67M Activated in VL: True Average Daily Range Avg Daily Range: $0.28 | 3.70% Avg Daily Range (30 D): $0.05 | 5.27% Avg Daily Range (90 D): $0.05 | 4.61% Institutional Daily Volume Avg Daily Volume: 1.06M Avg Daily Volume (30 D): .99M Avg Daily Volume (90 D): .99M Trade Size Avg Trade Size (Sh.): 135 Avg Trade Size (Sh.) (30 D): 265 Avg Trade Size (Sh.) (90 D): 237 Institutional Trades Total Inst.Trades: 501 Avg Inst. Trade: $1.75M Avg Inst. Trade (30 D): $1.52M Avg Inst. Trade (90 D): $1.52M Avg Inst. Trade Volume: .26M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.84M Avg Closing Trade (30 D): $1.52M Avg Closing Trade (90 D): $1.52M Avg Closing Volume: 277.43K     News May 6, 2025 @ 8:00 PM Caribou Biosciences to Participate in the BofA Sec... Source: N/A Feb 22, 2025 @ 2:19 PM CRBU DEADLINE NOTICE: ROSEN, NATIONAL TRIAL COUNSE... Source: N/A Feb 19, 2025 @ 9:00 PM CRBU INVESTOR ALERT: Bronstein, Gewirtz & Grossman... Source: Bronstein, Gewirtz & Grossman, Llc Feb 16, 2025 @ 2:15 PM CRBU IMPORTANT DEADLINE: ROSEN, LEADING TRIAL ATTO... Source: N/A Feb 13, 2025 @ 10:46 PM CRBU DEADLINE ALERT: ROSEN, A LEADING LAW FIRM, En... Source: N/A Financials   TTM Q1 2025 Q4 2024 Basic EPS $-1.62 $-.43 $-.39 Diluted EPS $-1.62 $-.43 $-.39 Revenue $ 9.92M $ 2.35M $ 2.08M Gross Profit $ $ $ Net Income / Loss $ -147.86M $ -39.99M $ -35.49M Operating Income / Loss $ -163.53M $ -42.91M $ -38.88M Cost of Revenue $ $ $ Net Cash Flow $ -19.98M $ 13.12M $ -15.68M PE Ratio